Yüklüyor......
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer
RG7787 is a re-engineered mesothelin-targeted immunotoxin with reduced immunogenicity composed of a humanized anti-mesothelin Fab fragment and a B-cell epitope silenced 24 kD fragment of Pseudomonas exotoxin A. High prevalence of mesothelin-positive cases and a large unmet medical need make ovarian...
Kaydedildi:
Yayımlandı: | Sci Rep |
---|---|
Asıl Yazarlar: | , , , , , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2017
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741731/ https://ncbi.nlm.nih.gov/pubmed/29273809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-17329-7 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|